Jul 3 |
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
|
Jul 2 |
Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
|
Jul 1 |
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
|
Jul 1 |
Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
|
Jul 1 |
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
|
Jul 1 |
Sanofi reports findings from Phase II relapsing MS treatment trial
|
Jul 1 |
Sanofi eyes German insulin investment of up to $1.6 billion, source says
|
Jun 29 |
Where Will Novavax Be in 1 Year?
|
Jun 28 |
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
|
Jun 28 |
3 Top Euronext Paris Dividend Stocks With Yields From 4% To 5.1%
|